GlaxoSmithkline (GSK) Consumer Healthcare Ltd today reported a 36.85 per cent increase in standalone net profit at Rs 219.37 crore for the second quarter ended September 30, driven by cost efficiencies.
The company had reported a net profit of Rs 160.29 crore in the same quarter a year ago.
However, the company's net sales increased marginally to Rs 1,074.70 crore as against Rs 1,074.66 crore in the corresponding period last year, the company said in a BSE filing.
"Our financial performance has been consistent which exhibits consumer confidence in our brands. We continue to gain share in the HFD category as a result of the focus around our consumer connect marketing initiatives, thereby increasing our market presence and penetration", GSK Consumer Healthcare Managing Director Manoj Kumar said.
Shares of the company today settled at Rs 5,901.65 per scrip on BSE, up 0.78 per cent from previous close.
